Connect live...

Select the exhibitor's booth below and get connected live.

Click on "Edit" in the right panel to replace this with your own HTML code

Other exhibitors

Information

iCFO Information Booth How can we help?
Entrepreneur

Nob Hill Therapeutics Pioneering Respiratory Patient Care
Entrepreneur

PROOF Hard Ice Cream PROOF will be among the most highly recommended gourmet brands in the world
Entrepreneur

Kurve Therapeutics The Future of Systemic and Central Nervous System (CNS) Therapies - Bringing solutions to clinical unmet needs
Entrepreneur

Gel Dynamics A Vetted Solution With A Global Market
Entrepreneur

TracFlo A vertical SaaS Fintech focused on construction
Entrepreneur

VIC Tech A LIFE SCIENCE VENTURE STUDIO - Building a Healthy Future
Entrepreneur

Greentech Laboratories ADVANCING HUMAN LIFE WITH TECHNOLOGIES FOR INNER WELLBEING
Entrepreneur

Addimmune Addimmune’s sole purpose is to cure HIV. We believe it’s possible with gene and cell therapy.
Entrepreneur

MedAware Transforming patient safety
Entrepreneur

Titin KM Biomedical Corporation THE FUTURE OF SHOULDER REHABILITATION
Entrepreneur

CommerceBlitz Optimizing Inventory and Distribution Operations for eCommerce Businesses
Entrepreneur

Adlore Introducing SenLore - A Novel Device to Treat and Monitor Diabetic Foot Ulcers
Entrepreneur

Creative BioTherapeutics WE START WHERE OTHER THERAPIES FAIL FOR RECURRENT & DRUG RESISTANT CANCERS

Event DealConnect 360: The Ultimate Deal Room for Real Results! is over.
Join us next time to meet Tim Patrick!

About Ventis Pharma

Ventis Pharma

Improving pain relief for every patient

Available from 12:00 PM - 4:00 PM (US/Pacific)

http://WWW.VENTISPHARMA.COM

tpatrick@ventispharma.com

+1 949-303-9143

Ventis Pharma is a bio-pharmaceutical company which focuses on vertical product lines that bring an assortment of new medications and solutions to drug issues in the clinical anesthesia space, the pediatric space as well as commercializing an innovative medical device for operating rooms. Ventis has additional drug development on-going, as well as a clinical partnerships with a European Pharma company. Our product diversity provides a reduced investment risk to our investors.